InterOcean Capital Group LLC Decreases Stock Holdings in Danaher Co. (NYSE:DHR)

InterOcean Capital Group LLC decreased its position in Danaher Co. (NYSE:DHR) by 21.2% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 2,933 shares of the conglomerate’s stock after selling 791 shares during the quarter. InterOcean Capital Group LLC’s holdings in Danaher were worth $732,000 at the end of the most recent quarter.

A number of other hedge funds have also recently modified their holdings of the company. ST Germain D J Co. Inc. lifted its holdings in shares of Danaher by 1.4% in the 1st quarter. ST Germain D J Co. Inc. now owns 2,880 shares of the conglomerate’s stock worth $719,000 after acquiring an additional 41 shares during the last quarter. Godsey & Gibb Inc. lifted its holdings in shares of Danaher by 3.0% in the 1st quarter. Godsey & Gibb Inc. now owns 1,442 shares of the conglomerate’s stock worth $360,000 after acquiring an additional 42 shares during the last quarter. Nicholas Hoffman & Company LLC. lifted its holdings in shares of Danaher by 2.3% in the 4th quarter. Nicholas Hoffman & Company LLC. now owns 1,899 shares of the conglomerate’s stock worth $439,000 after acquiring an additional 43 shares during the last quarter. Los Angeles Capital Management LLC lifted its holdings in shares of Danaher by 1.3% in the 4th quarter. Los Angeles Capital Management LLC now owns 3,470 shares of the conglomerate’s stock worth $803,000 after acquiring an additional 43 shares during the last quarter. Finally, Berger Financial Group Inc lifted its holdings in shares of Danaher by 1.7% in the 4th quarter. Berger Financial Group Inc now owns 2,517 shares of the conglomerate’s stock worth $582,000 after acquiring an additional 43 shares during the last quarter. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Danaher Stock Up 1.6 %

Shares of Danaher stock traded up $4.33 on Thursday, reaching $270.09. The stock had a trading volume of 4,179,004 shares, compared to its average volume of 2,922,821. The company has a 50 day moving average price of $254.89 and a 200 day moving average price of $248.67. The company has a quick ratio of 1.51, a current ratio of 1.85 and a debt-to-equity ratio of 0.31. Danaher Co. has a 1 year low of $182.09 and a 1 year high of $276.31. The stock has a market capitalization of $200.05 billion, a P/E ratio of 45.04, a P/E/G ratio of 4.11 and a beta of 0.83.

Danaher (NYSE:DHR) last issued its quarterly earnings data on Tuesday, July 23rd. The conglomerate reported $1.72 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.57 by $0.15. The firm had revenue of $5.74 billion for the quarter, compared to the consensus estimate of $5.59 billion. Danaher had a net margin of 16.94% and a return on equity of 10.90%. The company’s quarterly revenue was down 2.9% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $2.05 EPS. As a group, equities research analysts forecast that Danaher Co. will post 7.62 EPS for the current year.

Danaher Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, July 26th. Shareholders of record on Friday, June 28th will be given a dividend of $0.27 per share. This represents a $1.08 annualized dividend and a yield of 0.40%. The ex-dividend date is Friday, June 28th. Danaher’s dividend payout ratio is presently 18.31%.

Wall Street Analyst Weigh In

Several research firms have recently issued reports on DHR. HSBC upgraded shares of Danaher from a “hold” rating to a “buy” rating and raised their target price for the stock from $250.00 to $280.00 in a report on Wednesday, April 17th. TD Cowen lifted their price objective on shares of Danaher from $290.00 to $310.00 and gave the company a “buy” rating in a report on Wednesday. Robert W. Baird lifted their price objective on shares of Danaher from $271.00 to $278.00 and gave the company an “outperform” rating in a report on Wednesday. Barclays lifted their price objective on shares of Danaher from $270.00 to $285.00 and gave the company an “equal weight” rating in a report on Wednesday. Finally, Bank of America lifted their price objective on shares of Danaher from $270.00 to $275.00 and gave the company a “neutral” rating in a report on Wednesday. Six investment analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $276.88.

Insiders Place Their Bets

In other Danaher news, CEO Rainer Blair sold 9,005 shares of the business’s stock in a transaction that occurred on Thursday, May 16th. The shares were sold at an average price of $265.00, for a total transaction of $2,386,325.00. Following the sale, the chief executive officer now owns 106,990 shares of the company’s stock, valued at approximately $28,352,350. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. In other Danaher news, CEO Rainer Blair sold 9,005 shares of Danaher stock in a transaction that occurred on Thursday, May 16th. The shares were sold at an average price of $265.00, for a total transaction of $2,386,325.00. Following the completion of the sale, the chief executive officer now directly owns 106,990 shares in the company, valued at approximately $28,352,350. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CFO Matthew Mcgrew sold 46,377 shares of the business’s stock in a transaction on Friday, May 10th. The shares were sold at an average price of $253.05, for a total transaction of $11,735,699.85. Following the completion of the transaction, the chief financial officer now owns 29,407 shares of the company’s stock, valued at $7,441,441.35. The disclosure for this sale can be found here. In the last quarter, insiders have sold 75,175 shares of company stock valued at $19,161,154. Insiders own 11.10% of the company’s stock.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.